YM150 Phase III Study - An Open-Label, Multi-Center Study in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities.
Phase of Trial: Phase III
Latest Information Update: 15 Jun 2010
At a glance
- Drugs Darexaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 15 Jun 2010 Actual end date (April 2010) added as reported by ClinicalTrials.gov.
- 15 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.